Publikationen, an denen er mitarbeitet FERMI JOSEP MONTO GUILLOT (8)

2022

  1. Beta-3 adrenergic receptor overexpression reverses aortic stenosis–induced heart failure and restores balanced mitochondrial dynamics

    Basic Research in Cardiology, Vol. 117, Núm. 1

2021

  1. NT3/TrkC Pathway Modulates the Expression of UCP-1 and Adipocyte Size in Human and Rodent Adipose Tissue

    Frontiers in Endocrinology, Vol. 12

2017

  1. Activation of α1A-adrenoceptors desensitizes the rat aorta response to phenylephrine through a neuronal NOS pathway, a mechanism lost with ageing

    British Journal of Pharmacology, Vol. 174, Núm. 13, pp. 2015-2030

2015

  1. β2-and β1-adrenoceptor expression exhibits a common regulatory pattern with GRK2 and GRK5 in human and animal models of cardiovascular diseases

    Journal of Cardiovascular Pharmacology, Vol. 66, Núm. 5, pp. 478-486

2014

  1. Action of an extract from the seeds of Fraxinus excelsior L. on metabolic disorders in hypertensive and obese animal models

    Food and Function, Vol. 5, Núm. 4, pp. 786-796

2012

  1. Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure ethiology and correlates to clinical variables

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 303, Núm. 3, pp. 368-376

2010

  1. The impact of α1-adrenoceptors up-regulation accompanied by the impairment of β-adrenergic vasodilatation in hypertension (The Journal of Pharmacology and Experimental Therapeutics (2009) 328, (982-990))

    Journal of Pharmacology and Experimental Therapeutics

2009

  1. The Impact of α1-Adrenoceptors Up-regulation accompanied by the mpairment of β-adrenergic vasodilatation in hypertension

    Journal of Pharmacology and Experimental Therapeutics, Vol. 328, Núm. 3, pp. 982-990